Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034871 | 12703487 | 1 | I | 20160617 | 20160818 | 20160831 | 20160831 | EXP | US-TEVA-689189USA | TEVA | 72.00 | YR | M | Y | 93.12000 | KG | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034871 | 12703487 | 1 | PS | WARFARIN | WARFARIN | 1 | Oral | 5 MILLIGRAM DAILY; | Y | 40145 | 5 | MG | QD | ||||||
| 127034871 | 12703487 | 2 | C | PF-04950615 | BOCOCIZUMAB | 1 | Subcutaneous | 0 | QOW | ||||||||||
| 127034871 | 12703487 | 3 | C | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Subcutaneous | 0 | QOW | ||||||||||
| 127034871 | 12703487 | 4 | C | GLUCOPHAGE XR | METFORMIN HYDROCHLORIDE | 1 | Oral | 2000 MILLIGRAM DAILY; | 0 | 1000 | MG | BID | |||||||
| 127034871 | 12703487 | 5 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 127034871 | 12703487 | 6 | C | NITROSTAT/glyceryl trinitrate | 2 | Sublingual | 0 | .4 | MG | ||||||||||
| 127034871 | 12703487 | 7 | C | insulin aspart/ protamine | 2 | Sunconjunctival | 36 UNITS EVERY MORNING AND 46 UNITS EVERY EVENING | 0 | |||||||||||
| 127034871 | 12703487 | 8 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | |||||||
| 127034871 | 12703487 | 9 | C | SOTALOL. | SOTALOL | 1 | Oral | 80 MILLIGRAM DAILY; | 0 | 40 | MG | BID | |||||||
| 127034871 | 12703487 | 10 | C | ZEGERID OTC (omeprazole/ sodium bicarbonate) | 2 | Oral | 20/1100 | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127034871 | 12703487 | 1 | Atrial fibrillation |
| 127034871 | 12703487 | 2 | Cardiovascular disorder |
| 127034871 | 12703487 | 4 | Diabetes mellitus |
| 127034871 | 12703487 | 6 | Chest pain |
| 127034871 | 12703487 | 7 | Diabetes mellitus |
| 127034871 | 12703487 | 8 | Hyperlipidaemia |
| 127034871 | 12703487 | 10 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127034871 | 12703487 | HO |
| 127034871 | 12703487 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127034871 | 12703487 | Body temperature decreased | |
| 127034871 | 12703487 | Bradycardia | |
| 127034871 | 12703487 | Haematoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127034871 | 12703487 | 1 | 20140131 | 0 | ||
| 127034871 | 12703487 | 2 | 20150827 | 0 | ||
| 127034871 | 12703487 | 3 | 20150827 | 0 | ||
| 127034871 | 12703487 | 4 | 20061221 | 0 | ||
| 127034871 | 12703487 | 5 | 20061221 | 0 | ||
| 127034871 | 12703487 | 6 | 20141110 | 0 | ||
| 127034871 | 12703487 | 7 | 20141203 | 0 | ||
| 127034871 | 12703487 | 8 | 20160418 | 0 | ||
| 127034871 | 12703487 | 9 | 20130507 | 0 | ||
| 127034871 | 12703487 | 10 | 20140131 | 0 |